Is Johnson & Johnson halal to invest in?

As of August 2026, Johnson & Johnson JNJ.VI is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Johnson & Johnson a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Johnson & Johnson using these criteria to determine its compliance status.

Can Muslims buy shares of Johnson & Johnson?

Muslim investors may consider investing in Johnson & Johnson if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Johnson & Johnson classified as HALAL?

Musaffa determines the Shariah status of Johnson & Johnson by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Johnson & Johnson updated?

The Shariah compliance status of Johnson & Johnson may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Johnson & Johnson become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Johnson & Johnson?

You can check the latest Shariah compliance status of Johnson & Johnson on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Johnson & Johnson JNJ.VI

Last Updated: Aug 10, 12:00 AM·WBAG

JNJ.VI Shariah Compliance

Screening Methodology: AAOIFI

As of August 2026, Johnson & Johnson is classified as halal.

HALAL

Report Source: undefined Quarter Report

Johnson & Johnson. Stock Analysis JNJ.VI

Austria Health Care Mega Cap

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. The company is headquartered in New Brunswick, New Jersey and currently employs 138,200 full-time employees. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).